Get started
Author

Jade Peres

Observed names: J Peres, Peres, Jade, Peres, Jade Pereira de Andrade
Observed institution: University of Cape Town
ORCID: 0000-0001-8568-4840
Observed ORCID: 0000-0001-8568-4840
OpenAlex ID: A5008735570
The roles and regulation of TBX3 in development and disease
2019 · Saif F. Khan, Victoria Damerell, et al. · Gene · 99
T-box transcription factors in cancer biology
2014 · Sabina Wansleben, Jade Peres, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 65
The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion
2013 · Jade Peres, Sharon Prince · Molecular Cancer · 50
PDF
The T-Box transcription factor 3 in development and cancer
2017 · Tarryn Willmer, Aretha Cooper, et al. · BioScience Trends · 44
PDF
The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis
2014 · Jade Peres, Shaheen Mowla, et al. · Oncotarget · 40
PDF
The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor
2017 · Jade Peres, Eliza M. Kwesi-Maliepaard, et al. · Cancer Letters · 39
The T-box transcription factor TBX3 drives proliferation by direct repression of the p21WAF1 cyclin-dependent kinase inhibitor
2016 · Tarryn Willmer, Shannagh Hare, et al. · Cell Division · 37
PDF
A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance
2013 · S Wansleben, E Davis, et al. · Cell Death and Disease · 35
PDF
Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivo
2017 · Rupal Jivan, Jade Peres, et al. · Cancer Letters · 34
The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2
2015 · Tarryn Willmer, Jade Peres, et al. · Cell Cycle · 32
PDF
The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells
2014 · Saeb Aliwaini, Jade Peres, et al. · Cancer Letters · 29
Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK
2018 · Tanja Davis, Gustav van Niekerk, et al. · Biochemical Pharmacology · 27
Metformin‐induced alterations in nucleotide metabolism cause 5‐fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma
2017 · Charissa Mynhardt, Leonard H. Damelin, et al. · Journal of Cellular Biochemistry · 20
Targeting the Oncogenic TBX2 Transcription Factor With Chromomycins
2020 · Bianca Del B. Sahm, Jade Peres, et al. · Frontiers in Chemistry · 14
PDF
The c-Myc/AKT1/TBX3 Axis Is Important to Target in the Treatment of Embryonal Rhabdomyosarcoma
2020 · Danica Sims, Hapiloe Mabaruti Maranyane, et al. · Cancers · 13
PDF
TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF
2021 · Jade Peres, Victoria Damerell, et al. · Journal of Investigative Dermatology · 10
PDF
Cytoskeletal tubulin competes with actin to increase deformability of metastatic melanoma cells
2020 · Ghodeejah Higgins, Jade Peres, et al. · Experimental Cell Research · 4
PDF
Tendon‐like tether formation for tongue‐base advancement in an ovine model using a novel implant device intended for the surgical management of obstructive sleep apnoea
2020 · Rushdi Hendricks, Elena Hofmann, et al. · Journal of Biomedical Materials Research Part B Applied Biomaterials · 2
Intracellular mechanics and TBX3 expression jointly dictate the spreading mode of melanoma cells in 3D environments
2023 · Ghodeejah Higgins, Faatiemah Higgins, et al. · Experimental Cell Research · 1
PDF
Abstract B43: The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma
2020 · Danica Anne Sims, Hapiloe Mabaruti Maranyane, et al. · Cancer Research · 1
Corrigendum to ‘TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF’ Journal of Investigative Dermatology, Volume 141, Issue 9, September 2021, Pages 2250-2260
2025 · Jade Peres, Victoria Damerell, et al. · Journal of Investigative Dermatology
PDF
Abstract B19: The oncogenic TBX2 activates the ATM-CHK2-p53 axis to confer cisplatin resistance in breast cancer and melanoma
2016 · Serah Kimani, Sabina Wansbelen, et al. · Molecular Cancer Research
Works count: 28
Citation count: 596
H-index: 14
I10-index: 16
Year
Topic
Type